Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Controlled Survey Study to Assess the Safety of Treating Migraine With Nerivio During Pregnancy and 3 Months Postpartum

NCT05464069 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT05464069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05464069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Controlled Survey Study to Assess the Safety of Treating Migraine With Nerivio During Pregnancy and 3 Months Postpartum
Lead sponsor
Theranica
Phase
Observational
Overall status
Completed
Start date
August 1, 2022
Completion date
December 7, 2022
Enrollment
145 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, pregnancy related